EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Hypertension in Jordan: Prevalence, Awareness, Control, and Its Associated Factors

Yousef Khader, Anwar Batieha, Hashem Jaddou, Sukaina I. Rawashdeh, Mohammed El-Khateeb, Dana Hyassat, Albaraa Khader, Kamel Ajlouni

International Journal of Hypertension · 2019-01 · 2019 (1)

DOI: 10.1155/2019/3210617 ↗
AbstractBibliografische Angaben

Abstract

Objectives . Determine the prevalence, awareness, and control rates of hypertension and their associated factors among Jordanian adults. Methods . A multistage sampling technique was used to select a nationally representative sample of adults from the population of Jordan. Trained interviewers collected data using a comprehensive structured questionnaire, measured anthropometric parameters, and collected blood samples. Results . This study included a total of 1193 men and 2863 women aged ranged from 18 to 90 year with a mean (SD) of 43.8 (14.2) year. The age‐standardized prevalence was 33.8% among men and 29.4% among women. Of those with hypertnsion, 57.7% of men and 62.5% of women were aware of hypertension. Only 30.7% of men and 35.1% of women who were on antihypertensive medications had their blood pressure controlled. From 2009 to 2017, there was nonsignificant decrease in hypertension prevalence of 2.7% among men and 1.1% among women. However, the rate of hypertension awareness increased significantly among men and among women. Discussion . Almost one‐third of Jordanian adults had hypertension. Interventions that target modifiable risk factors of hypertension, might decrease blood pressure, and even prevent the development of hypertension should be implemnted.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →